Wellcome Sanger Institute
Sanger Institute Science Collaboration
Collaboration
Human Genetics

UK Inflammatory Bowel Disease Genetics Consortium

The UKIBD Genetics Consortium (UKIBDGC) comprises clinicians and scientists with a track record of successful collaborative research in the genetics of inflammatory bowel disease. Our aims are to identify and understand the genes that determine disease susceptibility, course and response and side effects of treatment. The UKIBDGC is a major contributor to the International IBD Genetics Consortium.

Contact

If you need help or have any queries, please contact us using the details below.

Email: ca3@sanger.ac.uk

Sanger people

Photo of Dr Carl Anderson

Dr Carl Anderson

Interim Head of Human Genetics and Senior Group Leader

Related groups

 

Science group

Anderson Group

Genomics of inflammation and immunity

The goal of our research is to use high-throughput screens to gain causal insights into the biological basis of human disease, ...
 
Wellcome Sanger Institute

Programmes and Facilities

 

Programme

Human Genetics

The Human Genetics Programme is driving a step-change in our understanding of genetic causes and biological mechanisms of disease susceptibility and ...